http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Zevra Therapeutics (ZVRA) to Join Nasdaq Biotechnology Index (NBI)
-
Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
-
Savara Added to the NASDAQ Biotechnology Index
-
Oyster Point Pharma Inc. (OYST) Announces Addition To Nasdaq Biotechnology Index
-
Oyster Point Pharma Announces Addition To Nasdaq Biotechnology Index
-
KemPharm (KMPH) to be Added to the Nasdaq Biotechnology Index Effective December 20
-
Sensei Biotherapeutics (SNSE) Announces Addition to the Nasdaq Biotechnology Index
-
NASDAQ (NDAQ) Announces Changes to the Nasdaq Biotechnology Index
-
Annual Changes to the Nasdaq Biotechnology Index
-
Arcutis Biotherapeutics Inc. (ARQT) Added to Nasdaq Biotechnology Index
-
Arcutis Biotherapeutics Added to Nasdaq Biotechnology Index
-
Provention Bio Announces Addition to NASDAQ Biotechnology Index
-
Gamida Cell Added to NASDAQ Biotechnology Index
-
Poseida Therapeutics Added to NASDAQ Biotechnology Index
-
Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index
-
Applied Therapeutics to be Added to NASDAQ Biotechnology Index
-
Legend Biotech Added to the NASDAQ Biotechnology Index
-
I-Mab Added to Nasdaq Biotechnology Index
-
Stoke Therapeutics Added to NASDAQ Biotechnology Index
-
Scholar Rock Added to NASDAQ Biotechnology Index
-
Annual Changes to the NASDAQ Biotechnology Index
-
Annual Changes to the NASDAQ Biotechnology Index
-
Rubius Therapeutics Added to Nasdaq Biotechnology Index
-
Rubius Therapeutics Added to Nasdaq Biotechnology Index
-
Savara Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
-
G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights
-
Savara Added to Nasdaq Biotechnology Index
-
CytomX Therapeutics Added to NASDAQ Biotechnology Index
-
G1 Therapeutics Added to Nasdaq Biotechnology Index
-
G1 Therapeutics Added to Nasdaq Biotechnology Index
-
Global Blood Therapeutics Reports Recent Business Progress and Fourth Quarter and Year-End 2016 Financial Results
-
NantHealth Added to Nasdaq Biotech Index
-
Flex Pharma Reports Year End 2015 Financial Results
-
Arrowhead Research (ARWR) to Join NASDAQ Biotechnology Index (NBI)
-
Arrowhead Added to NASDAQ Biotechnology Index®

